Dynamic Quadriceps Muscle Stimulation for Treatment of Patellofemoral Pain
1 other identifier
interventional
20
1 country
1
Brief Summary
The purpose of this small, pilot study is to evaluate a novel device that uses neuromuscular electrical stimulation to assist quadriceps muscles as a user walks. This study will involve use of this device on individuals with patellofemoral pain, a relatively common injury among active people, to see if quadriceps stimulation could mitigate disparities in quadriceps activation timing that may indirectly lead to knee pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 12, 2014
CompletedFirst Posted
Study publicly available on registry
September 17, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2017
CompletedJune 27, 2017
June 1, 2017
2.5 years
September 12, 2014
June 26, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measured Quadriceps Musculature Co-Contraction
Electromyographic (EMG) readings of vastus lateralis and vastus medialis contraction patterns will be taken after four six-minute walk tests (6MWTs) to evaluate any short-term changes in co-contraction. 6MWT #1: Without interventional device being worn; 6MWT #2: With interventional device being worn, but unpowered; 6MWT #3: With interventional device being worn and operational; 6MWT #4: Without interventional device being worn The time period in which a partipant will be involved is not expected to exceed 90 minutes.
20, 40, 60, 80 minutes from start of single-day testing
Secondary Outcomes (2)
Anterior Knee Pain
20, 40, 60, 80 minutes from start of single-day testing
Device Joint Model Accuracy
20, 40, 60, 80 minutes from start of single-day testing
Study Arms (1)
Device (rehabilitation assistance)
EXPERIMENTALDevice: KneeStim mobile rehabilitation assistance device
Interventions
KneeStim is a neuromuscular electrical stimulation (NMES) device that integrates motion-tracking hardware like three-axis accelerometers and a real-time operating system to enable quadriceps muscle stimulation in time with user gait. It is a completely non-invasive device that looks like a light brace and fastens to the user's quadriceps and gastrocnemius muscles. The end goal of this device is to assist with muscle re-strengthening and re-education during a user's everyday activities.
Eligibility Criteria
You may qualify if:
- Aged 18-40 years
- Symptomatic PFPS on Patella Glide Test, Patella Tilt Test, and Patellar Apprehension Test.
You may not qualify if:
- Rheumatoid arthritis or inflammatory arthritis as assessed by licensed physician
- Use of walking aids other than a cane more than 50% of the time in ambulation
- Diagnosed knee disorder other than patellofemoral syndrome
- Pacemaker use, unstable angina, or decompensated heart failure
- Knee replaced in preceding 12 months or replacement planned within 6 months
- Moderate to severe dementia
- Pregnancy (self report)
- Altered sensation at the knee such that the patient is unable to perceive the presence of pinprick.
- Use of intra-articular viscosupplementation or steroid injection within preceding 2 months.
- Use of chronic anticoagulation medication.
- Movement-limiting pain in the back, hip, ankle, or foot of either lower limb.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Articulate Labslead
- University of Texas at Austincollaborator
Study Sites (1)
Developmental Motor Control Lab; University of Texas at Austin
Austin, Texas, 78712, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lisa Griffin, Ph.D.
University of Texas at Austin
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 12, 2014
First Posted
September 17, 2014
Study Start
September 1, 2014
Primary Completion
March 1, 2017
Study Completion
March 1, 2017
Last Updated
June 27, 2017
Record last verified: 2017-06